Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
No intraday reading yet this session.
Arvinas, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
199 institutional managers report a position in Arvinas, Inc. worth $462.2M between them, filed on form 13F for the quarter ending 2026-06-30. 27 of them hold 80% of it, the largest being BlackRock, Inc. at 13.68%.
174 more managers in the register
27 managers hold 80% of the $462.2M institutional base. The other 172 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
ARVN (Arvinas, Inc.) has 1 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: NVS +0.51%, in healthcare.
via Armistice Capital, LLC, Jacobs Levy Equity Management, Inc, Federated Investors Inc +4 more · 5.03% of ARVN, 8.64% of IRWD
via Armistice Capital, LLC, Federated Investors Inc, Jacobs Levy Equity Management, Inc +2 more · 5.03% of ARVN, 5.68% of INGN
via Pfizer Inc, Acadian Asset Management LLC, Qube Research & Technologies Ltd +4 more · 5.98% of ARVN, 9.24% of CRBU
via Qube Research & Technologies Ltd, Jacobs Levy Equity Management, Inc, Federated Investors Inc +5 more · 2.86% of ARVN, 3.28% of KROS
via Armistice Capital, LLC, Jacobs Levy Equity Management, Inc, Acadian Asset Management LLC +3 more · 5.03% of ARVN, 10.30% of MGNX
via Armistice Capital, LLC, Qube Research & Technologies Ltd, Acadian Asset Management LLC +3 more · 5.03% of ARVN, 9.01% of BCYC
Managers holding a meaningful stake in ARVN also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.